Bionow | News

The PR Challenge of a Slow Moving Health Crisis

Feb 19th 2025

In a fascinating discussion, Gabriella Elia and Chris Hulme explore the communication challenges of AMR with Professor Janet Hemingway, founder of iiCON; Dr Neil Murray, CEO of Renewvax and...

BioInfect 2025 sees a great turnout for a day of AMR discussion

Feb 7th 2025

BioInfect returned to The Spine in Liverpool for the second year in a row on 5th February, with over 175 delegates, 14 exhibitors and 15 poster abstracts focusing on the issues surrounding t...

Health experts, academics, business leaders and local students will take centre ...

Jan 27th 2025

The BioInfect conference returns to Liverpool’s The Spine on Wednesday 5th February, with the one-day event promising to shed light on how the increasing threat of antimicrobial resistance...

Global AMR Challenge Receives a £5m Boost to Drive Diagnostics Innovation

Sep 26th 2024

PACE (Pathways to Antimicrobial Clinical Efficacy) has today launched its second funding round with up to £5 million available to support cutting-edge diagnostic projects. This funding is p...

CF AMR Syndicate Announces First Awardees of £3m Collaborative Drug Discovery P...

Sep 24th 2024

The Cystic Fibrosis Antimicrobial Resistance Syndicate has today announced the first cohort of awardees of its Collaborative Discovery Programme funding.

F2G announces $100 million financing to advance late-stage development and comme...

Sep 17th 2024

F2G Ltd, a clinical-stage biopharmaceutical company focused on the discovery and development of novel therapies to treat life-threatening rare fungal infections with a high unmet medical nee...

BioInfect 2024 celebrates new investment zone launch

Feb 12th 2024

In a brand-new venue for 2024, The Spine in Liverpool was home to BioInfect on 8th February for the first time, with another great turnout of 170 delegates, 11 exhibitors and 10 poster abstr...

CF AMR Syndicate Launches £3 million Collaborative Discovery Programme

Mar 16th 2023

Funding New Antimicrobials to Treat Lung Infections in People with Cystic Fibrosis

Putting AMR on the agenda at BioInfect 2023

Feb 3rd 2023

Seeing a fantastic turnout for 2023, this year’s BioInfect event was back at Alderley Park on 1st February, with a record 200 delegates, 20 exhibitors, 12 poster abstracts and 28 speakers ...

A cure for resistance? How ultra-long patent terms may entice pharma to address...

Jan 6th 2023

Addressing the antimicrobial resistance crisis will require a multifaceted approach - could extending patent terms encourage pharmaceutical companies to drive innovation in this area? Potte...

A potential gamechanger in beating antimicrobial resistance

Dec 19th 2022

A radical project involving a group of experts from the University of Huddersfield aims to develop a new method for the commercial production of Anti-microbial peptide’s (AMPs) and could o...

A night of celebration at the 20th Bionow Annual Awards Dinner

Apr 1st 2022

A highlight of the life sciences calendar and celebrating the achievements of the life science sector, the sold out 2021 Bionow Awards showcased the very best of this world class field.

News